| 摘要 |
FIELD: medicine.SUBSTANCE: composition containing nanoparticles comprising taxane and albumin is administered in the patient who previously received gemcitabine as a first-line anticancer therapy and showed a positive response to this treatment. Administering the composition accompanied the gemcitabine therapy.EFFECT: specified combined administration of the preparations as a second-line therapy of pancreatic cancer provides the more effective treatment of this disease.24 cl, 4 dwg, 7 tbl, 2 ex |
